Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,430 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia

NCT04629443

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Texas MD Anderson Cancer Center Department of Leukemia, Division of Cancer Medicine Houston, Texas, United States
  • Victorian Comprehensive Cancer Centre Melbourne, Australia
  • The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services Melbourne, Australia
  • Institut Paoli-Calmettes Marseille, France
View Trial Details
Completed

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients

NCT00590187

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Division of Hematology-Oncology Los Angeles, California, United States
  • Stanford Hospitals and Clinics Stanford, California, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

NCT04580121

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Peter MacCallum Cancer Centre; Medical Oncology Melbourne, Victoria, Australia
  • The Alfred Melbourne, Victoria, Australia
View all 23 locations
View Trial Details
Completed

Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory

NCT06429670

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Centre Hospitalier Pierre Oudot | Groupement hospitalier Nord Bourgoin, France
  • METROPOLE SAVOIE - SITE CHAMBERY, place Lucien Biset, Chambéry, France
  • CHU Clermont-Ferrand Site Estaing Clermont-Ferrand, France
  • Centre Hospitalier Annecy Genevois Épagny, France
View Trial Details
Completed

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

NCT03493646

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View Trial Details
Completed

Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

NCT01995578

Conditions
Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-up) Commack, New York, United States
View Trial Details

Related conditions